Invention Grant
- Patent Title: 4′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication
-
Application No.: US15013173Application Date: 2016-02-02
-
Publication No.: US09694028B2Publication Date: 2017-07-04
- Inventor: Mark Smith , Klaus G. Klumpp
- Applicant: Riboscience LLC
- Applicant Address: US CA Palo Alto
- Assignee: Riboscience LLC
- Current Assignee: Riboscience LLC
- Current Assignee Address: US CA Palo Alto
- Agency: GrayRobinson, P.A.
- Agent Jennifer L. Kisko
- Main IPC: C07H19/10
- IPC: C07H19/10 ; C07H19/20 ; A61K31/7072 ; A61K31/7068 ; A61K45/06 ; A61K38/21
Abstract:
The present disclosure relates to the compound of Formula I: Also disclosed are pharmaceutical compositions comprising the compound of Formula I, methods of using the compound of Formula I and/or compositions comprising the compound of Formula I for the treatment of HCV.
Public/Granted literature
- US20160220596A1 4'-AZIDO, 3'-DEOXY-3'-FLUORO SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION Public/Granted day:2016-08-04
Information query
IPC分类:
